|
05-2028
|
AHEAD Plasma Extension (APEX)
AHEAD Plasma Extension (APEX)
|
|
04-2028
|
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
|
|
06-2027
|
WN42444, entitled, "A PHASE III, MULTICENTER, RANDOMIZED
WN42444, entitled, "A PHASE III, MULTICENTER, RANDOMIZED
|
|
02-2027
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled,
A Phase 3, Randomized, Double-Blind, Placebo-Controlled,
|
|
04-2026
|
A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlle
A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlle
|
|
11-2025
|
A Randomized, Double-blind, Placebo-controlled, Parallel
A Randomized, Double-blind, Placebo-controlled, Parallel
|
|
06-2025
|
Protocol #221AD304
Protocol #221AD304
|
|
05-2025
|
Longitudinal Follow-up of Clinical Trial Participants Fo
Longitudinal Follow-up of Clinical Trial Participants Fo
|
|
01-2025
|
Protocol #BAN2401-G000-301
Protocol #BAN2401-G000-301
|
|
10-2024
|
ACTC AHEAD Alzheimer's Association Proposal: Diverse Rec
ACTC AHEAD Alzheimer's Association Proposal: Diverse Rec
|
|
08-2024
|
Alzheimer's Clinical Trials Consortium (ACTC)
Alzheimer's Clinical Trials Consortium (ACTC)
|
|
06-2024
|
Alzheimer's Network for Treatment and Diagnostics
Alzheimer's Network for Treatment and Diagnostics
|
|
06-2024
|
A Phase 2A Randomized Double-Blind Placebo-Controlled Tr
A Phase 2A Randomized Double-Blind Placebo-Controlled Tr
|
|
05-2024
|
New IDEAS: Imaging Dementia - Evidence for Amyloid Scann
New IDEAS: Imaging Dementia - Evidence for Amyloid Scann
|
|
04-2024
|
Protocol #BHV4157-203
Protocol #BHV4157-203
|
|
12-2023
|
Protocol #WN39658
Protocol #WN39658
|
|
10-2023
|
Protocol #M15-570
Protocol #M15-570
|
|
06-2023
|
A Phase 2A study to evaluate safety, tolerability and p
A Phase 2A study to evaluate safety, tolerability and p
|
|
04-2023
|
Protocol #I5T-MC-AACI
Protocol #I5T-MC-AACI
|
|
01-2023
|
Protocol #ADC-051
Protocol #ADC-051
|
|
12-2022
|
Protocol #API015A2201J
Protocol #API015A2201J
|
|
11-2022
|
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials
|
|
10-2022
|
ACTC AHEAD Alzheimer's Association Proposal: Diverse Rec
ACTC AHEAD Alzheimer's Association Proposal: Diverse Rec
|
|
09-2022
|
Protocol: SNS-AD-001
Protocol: SNS-AD-001
|
|
06-2022
|
Protocol #MIRO_002_2018
Protocol #MIRO_002_2018
|
|
06-2022
|
Protocol #MIRO_003_2018
Protocol #MIRO_003_2018
|
|
04-2022
|
Global Alzheimer's Platform Trial-Ready Cohort for Precl
Global Alzheimer's Platform Trial-Ready Cohort for Precl
|
|
02-2022
|
Protocol #F-AV-45-A25
Protocol #F-AV-45-A25
|
|
12-2021
|
Protocol #M15-566
Protocol #M15-566
|
|
10-2021
|
Protocol #FNMI-002
Protocol #FNMI-002
|
|
05-2021
|
Protocol #CTP2S1502HT6
Protocol #CTP2S1502HT6
|
|
04-2021
|
Protocol #BN40031
Protocol #BN40031
|
|
03-2021
|
Protocol #CNP520A2202J
Protocol #CNP520A2202J
|
|
02-2021
|
A Phase 2A study to evaluate safety, tolerability and p
A Phase 2A study to evaluate safety, tolerability and p
|
|
01-2021
|
Protocol #BN29552
Protocol #BN29552
|
|
12-2020
|
Protocol #BAN2401-G000-303
Protocol #BAN2401-G000-303
|
|
10-2020
|
Protocol #IDEAS
Protocol #IDEAS
|
|
06-2020
|
Protocol #NeuroEM-1000-1
Protocol #NeuroEM-1000-1
|
|
05-2020
|
Combination of anti-amyloid therapy for preclinical Alzh
Combination of anti-amyloid therapy for preclinical Alzh
|
|
04-2020
|
The A3 Study: Ante-Amyloid prevention of Alzheimer's dis
The A3 Study: Ante-Amyloid prevention of Alzheimer's dis
|
|
04-2020
|
Global Alzheimer's Platform Trial-Ready Cohort for Precl
Global Alzheimer's Platform Trial-Ready Cohort for Precl
|
|
02-2020
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
02-2020
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
12-2019
|
Retention Funds - Alzheimer's Disease Cooperative Study - A4 Study
Retention Funds - Alzheimer's Disease Cooperative Study - A4 Study
|
|
06-2019
|
Protocol #54861911ALZ2003
Protocol #54861911ALZ2003
|
|
04-2019
|
Protocol #AV-1451-A18
Protocol #AV-1451-A18
|
|
04-2019
|
Protocol #I8D-MC-AZET
Protocol #I8D-MC-AZET
|
|
03-2019
|
Protocol #CN156-018-029
Protocol #CN156-018-029
|
|
09-2018
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
06-2018
|
Protocol #221AD301
Protocol #221AD301
|
|
11-2017
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
07-2017
|
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
|
|
06-2017
|
Protocol # 18F-AV-1451-A05
Protocol # 18F-AV-1451-A05
|
|
02-2017
|
Alzheimer's Disease Cooperative Study-A4 Study
Alzheimer's Disease Cooperative Study-A4 Study
|
|
12-2016
|
Tau PET Imaging for the USC Alzheimer's Therapeutic
Tau PET Imaging for the USC Alzheimer's Therapeutic
|
|
12-2016
|
Anti-Amyloid Treatment in Asympotomatic Alzheimer's Dise
Anti-Amyloid Treatment in Asympotomatic Alzheimer's Dise
|
|
11-2016
|
Protocol #MK-8931-019-00
Protocol #MK-8931-019-00
|
|
10-2016
|
Protocol #H8A-MC-LZAX
Protocol #H8A-MC-LZAX
|
|
09-2016
|
Protocol #TRx-237-005
Protocol #TRx-237-005
|
|
09-2016
|
Effects of Traumatic Brain Injury and Post Traumatic Str
Effects of Traumatic Brain Injury and Post Traumatic Str
|
|
09-2016
|
Protocol#161202
Protocol#161202
|
|
07-2016
|
Alzheimer's Disease Neuroimaging Initiative (ADNI2)
Alzheimer's Disease Neuroimaging Initiative (ADNI2)
|
|
05-2016
|
A Phase 2a Multi-Center Study of F-FDG PET, Safety
A Phase 2a Multi-Center Study of F-FDG PET, Safety
|
|
04-2016
|
Protocol #MK-8931-017-00
Protocol #MK-8931-017-00
|
|
04-2016
|
Protocol # Coconut Oil as treatment for Alzheimer's
Protocol # Coconut Oil as treatment for Alzheimer's
|
|
01-2016
|
Protocol# BAN2401-G000-201
Protocol# BAN2401-G000-201
|
|
09-2015
|
Effects of a Traumatic Brain Injury (TBI) and Post Traum
Effects of a Traumatic Brain Injury (TBI) and Post Traum
|
|
08-2015
|
Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Disease Neuroimaging Initiative
|
|
06-2015
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease
|
|
05-2015
|
ADC-049 FYN
ADC-049 FYN
|
|
04-2015
|
Protocol#AX-11-009
Protocol#AX-11-009
|
|
01-2015
|
Protocol#ELN 115727-351
Protocol#ELN 115727-351
|
|
01-2015
|
Protocol #ELN 115727-351
Protocol #ELN 115727-351
|
|
12-2014
|
Phase II study to evaluate the impact on biomarkers of Resveratrol treatment in patients with mild to moderate Alzheimer's Disease.
Phase II study to evaluate the impact on biomarkers of Resveratrol treatment in patients with mild to moderate Alzheimer's Disease.
|
|
11-2014
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
11-2014
|
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disea
|
|
06-2014
|
Protocol # CN156-013-037
Protocol # CN156-013-037
|
|
06-2014
|
Protocol # H8A-MC-LZAO
Protocol # H8A-MC-LZAO
|
|
04-2014
|
Protocol #CSSA 19-USF(IgIV)M-00-ADCS
Protocol #CSSA 19-USF(IgIV)M-00-ADCS
|
|
04-2014
|
Protocol #CSSA 19-USF (IgIV) M-00 ADCS
Protocol #CSSA 19-USF (IgIV) M-00 ADCS
|
|
03-2014
|
Protocol # ACC-001-ALZ-2001
Protocol # ACC-001-ALZ-2001
|
|
02-2014
|
Therapeutic Effect of Intranasal Insulin on Cognition, F
Therapeutic Effect of Intranasal Insulin on Cognition, F
|
|
05-2013
|
Protocol #ELN115727-301
Protocol #ELN115727-301
|
|
05-2013
|
Protocol #ELN115727-302
Protocol #ELN115727-302
|
|
05-2013
|
Protocol #ELND005-AD201
Protocol #ELND005-AD201
|
|
06-2012
|
ADCS Infrastructure Support
ADCS Infrastructure Support
|
|
05-2012
|
Protocol #1.4
Protocol #1.4
|
|
12-2011
|
Protocol #B0341002
Protocol #B0341002
|
|
08-2011
|
Protocol #1.4
Protocol #1.4
|
|
03-2011
|
Protocol #ELN-AIP-901
Protocol #ELN-AIP-901
|
